Adjuvant Sunitinib in Renal-Cell Carcinoma

被引：4
|
作者：
Zhang, Sheng [1 ]
机构：
[1] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2017年 / 376卷 / 09期
关键词：
RISK;
D O I：
10.1056/NEJMc1616636
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：893 / 893
页数：1
相关论文
共 50 条
  • [41] Re: Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
    Teh, Jiasian
    Narasimhan, Vignesh
    Schultz, Stephen
    Sathianathen, Niranjan
    Murphy, Declan G.
    EUROPEAN UROLOGY, 2019, 76 (01) : 126 - 127
  • [42] Avelumab plus axitinib vs. sunitinib for advanced renal-cell carcinoma
    Zhang, Yue
    Wu, Shenhong
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 : S585 - S588
  • [43] Tumour lysis syndrome in a patient with renal-cell carcinoma treated with sunitinib malate
    Nicholaou, Theo
    Wong, Rachel
    Davis, Ian D.
    LANCET, 2007, 369 (9577): : 1923 - 1924
  • [44] Re: Nivolumab plus Cabozantinib Versus Sunitinib for Advanced Renal-cell Carcinoma
    不详
    EUROPEAN UROLOGY, 2021, 80 (02) : 256 - 257
  • [45] Re: Nivolumab plus Ipilimumab Versus Sunitinib in Advanced Renal-cell Carcinoma
    Powles, Tom
    EUROPEAN UROLOGY, 2018, 74 (05) : 679 - 680
  • [46] BILATERAL RENAL-CELL CARCINOMA AND RENAL-CELL CARCINOMA IN THE SOLITARY KIDNEY
    SMITH, RB
    DEKERNION, JB
    EHRLICH, RM
    SKINNER, DG
    KAUFMAN, JJ
    JOURNAL OF UROLOGY, 1984, 132 (03): : 450 - 454
  • [47] RENAL-CELL CARCINOMA
    ALLHOFF, EP
    WORLD JOURNAL OF UROLOGY, 1991, 9 (04) : 167 - 167
  • [48] RENAL-CELL CARCINOMA
    GAY, BB
    ATKINSON, GO
    BALL, TI
    EDWARDS, K
    VANDERZALM, D
    AMERICAN JOURNAL OF ROENTGENOLOGY, 1983, 140 (05) : 1019 - 1019
  • [49] Renal-cell carcinoma
    Motzer, RJ
    Bander, NH
    Nanus, DM
    NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (12): : 865 - 875
  • [50] RENAL-CELL CARCINOMA
    STAEHLER, G
    UROLOGE-AUSGABE A, 1994, 33 (02): : 103 - 103
12345